Published: 12/01/2020 13:45 GMT (NSTM) - Novelstem Increases Newstem Ownership to 33% As Newstem Prepares for First-half 2021 FDA Filing for Approval of Its Stem-cell Based Anti-cancer Drug Resistance Diagnostic; Novelstem Initiates Process to Become Publicly-reporting With Sec.
and to Up-lis.
